Wang, Xiujuan
Wang, Qian
Xia, Ziyao
Yang, Ying
Dai, Xunan
Zhang, Chun
Wang, Jiaxian
Xu, Yongsheng
Funding for this research was provided by:
National Key Research and Development Project of Stem Cell and Transformation Research (2019YFA0112100)
Nanjing Science and Technology Foundation (202305002)
National Key R&D Program of China (2023YFC2506100)
Changping Key Research Project of the Beijing Natural Science Foundation Program (L234016)
Article History
Received: 9 July 2024
Accepted: 1 October 2024
First Online: 22 November 2024
Declarations
:
: Not applicable.
: Not applicable.
: Xiujuan Wang, Ying Yang and Yongsheng Xu are employees of Tianjin Everunion Biotechnology Co., Ltd. Qian Wang and Jiaxian Wang are employees of HELP Therapeutics Co., Ltd. The remaining authors declare no competing interests.